Abbott Laboratories 8-K 2009
Documents found in this filing:
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 20, 2009
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of principal executive offices)(Zip Code)
Registrants telephone number, including area code: (847) 937-6100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On February 20, 2009, Abbotts Board of Directors amended the first sentence of Article III, Section 2 of Abbotts by-laws to provide that Abbotts Board of Directors shall consist of thirteen persons, effective as of April 24, 2009. Abbotts by-laws previously provided that the Board of Directors consisted of fourteen persons.
On February 20, 2009, Abbotts Board of Directors also amended Article IV, Section 1 of Abbotts by-laws to provide that each committee of Abbotts Board of Directors shall have one or more members, effective as of February 20, 2009. Abbotts by-laws previously required each committee of the Board of Directors to have three or more members.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.